Rizwana Seeham

Rizwana Seeham has a diverse work experience spanning over several years. Rizwana currently holds the position of Director of Equity, Diversity, & Inclusion at Blueprint Medicines, a role they assumed in January 2024. Prior to this, they served as the Associate Director of Equity, Diversity, & Inclusion at the same company from July 2022 to January 2024. Rizwana also worked as a Senior Manager of Equity, Diversity, & Inclusion and GMP Quality Assurance from July 2021 to July 2022. Before joining Blueprint Medicines, they held the position of Manager of GMP Quality Assurance at the company from January 2020 to August 2021. Rizwana began their career as a Senior Associate in Quality Operations at Blueprint Medicines from February 2018 to January 2020. Prior to that, they worked as a Quality Assurance Operations Associate at Seres Therapeutics from May 2017 to February 2018. Rizwana also served as a Quality Assurance Specialist II at Takeda Oncology from January 2015 to May 2017. Their earliest experiences include working as a Cell Culture Associate II at Shire Pharmaceuticals from June 2012 to April 2014 and as a Cell Culture Associate I from October 2011 to June 2012.

Rizwana Seeham holds a Master of Science degree in Regulatory Affairs from The George Washington University. Rizwana also obtained a Bachelor's degree in Neuroscience from Boston University.